meglumine has been researched along with Peripheral Nervous System Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bäumer, P; Bendszus, M; Decker, C; Heiland, S; Pham, M; Radbruch, A; Reimann, M | 1 |
| Grayev, A; Hanna, A; Reeder, S | 1 |
| Ardid, D; Boucher, M; Coudoré-Civiale, MA; Courteix, C; Eschalier, A; Fialip, J; Méen, M | 1 |
| Blackburn-Munro, G; Dickinson, T; Fleetwood-Walker, SM | 1 |
1 trial(s) available for meglumine and Peripheral Nervous System Diseases
| Article | Year |
|---|---|
Peripheral nerve perfusion by dynamic contrast-enhanced magnetic resonance imaging: demonstration of feasibility.
Topics: Blood Flow Velocity; Blood Volume; Blood Volume Determination; Computer Simulation; Contrast Media; Feasibility Studies; Female; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Models, Biological; Organometallic Compounds; Peripheral Nerves; Peripheral Nervous System Diseases; Reproducibility of Results; Sensitivity and Specificity | 2014 |
3 other study(ies) available for meglumine and Peripheral Nervous System Diseases
| Article | Year |
|---|---|
Use of chemical shift encoded magnetic resonance imaging (CSE-MRI) for high resolution fat-suppressed imaging of the brachial and lumbosacral plexuses.
Topics: Adolescent; Adult; Aged; Brachial Plexus; Contrast Media; Female; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lumbosacral Plexus; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Peripheral Nervous System Diseases; Reproducibility of Results; Retrospective Studies; Signal-To-Noise Ratio; Young Adult | 2016 |
Potentiation of morphine and clomipramine analgesia by cholecystokinin -B antagonist CI-988 in diabetic rats.
Topics: Analgesia; Analgesics, Opioid; Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Clomipramine; Diabetes Mellitus, Experimental; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Indoles; Male; Meglumine; Morphine; Nociceptors; Pain; Pain Threshold; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Time Factors | 2000 |
Non-opioid actions of lamotrigine within the rat dorsal horn after inflammation and neuropathic nerve damage.
Topics: Action Potentials; Analgesics, Opioid; Animals; Anti-Anxiety Agents; Calcium Channel Blockers; Cholecystokinin; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Indoles; Inflammation; Lamotrigine; Male; Meglumine; Mustard Plant; Neural Pathways; Nociceptors; Opioid Peptides; Pain; Peripheral Nervous System Diseases; Plant Extracts; Plant Oils; Posterior Horn Cells; Rats; Rats, Wistar; Sincalide; Triazines | 2001 |